APA (7th ed.) Citation

V, M., S, R., A, G., TV, P., S, N. K., V, M., . . . A, S. (2025). Evaluation of safety and efficacy of multiple intravenous and intraosseous doses of foetal liver-derived mesenchymal stem cells in children with severe osteogenesis imperfecta: The BOOST2B clinical trial protocol. Bone & joint open, 6(3), 361. https://doi.org/10.1302/2633-1462.63.BJO-2024-0115.R1

Chicago Style (17th ed.) Citation

V, Madhuri, et al. "Evaluation of Safety and Efficacy of Multiple Intravenous and Intraosseous Doses of Foetal Liver-derived Mesenchymal Stem Cells in Children with Severe Osteogenesis Imperfecta: The BOOST2B Clinical Trial Protocol." Bone & Joint Open 6, no. 3 (2025): 361. https://doi.org/10.1302/2633-1462.63.BJO-2024-0115.R1.

MLA (9th ed.) Citation

V, Madhuri, et al. "Evaluation of Safety and Efficacy of Multiple Intravenous and Intraosseous Doses of Foetal Liver-derived Mesenchymal Stem Cells in Children with Severe Osteogenesis Imperfecta: The BOOST2B Clinical Trial Protocol." Bone & Joint Open, vol. 6, no. 3, 2025, p. 361, https://doi.org/10.1302/2633-1462.63.BJO-2024-0115.R1.